financetom
Business
financetom
/
Business
/
Market Chatter: Citigroup Reportedly Chosen to Lead Airtel Africa's $4 Billion Mobile Money IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Citigroup Reportedly Chosen to Lead Airtel Africa's $4 Billion Mobile Money IPO
Sep 2, 2025 5:39 AM

08:24 AM EDT, 09/02/2025 (MT Newswires) -- Citigroup ( C ) has reportedly been chosen by Airtel Africa to lead a planned initial public offering of its mobile money unit, Bloomberg reported Tuesday, citing unnamed people familiar with the matter.

No final decisions have been made on the size, timing or location of the deal, Bloomberg said.

Airtel Money is expecting to be valued at more than $4 billion, Bloomberg has reported, and company officials have scheduled a meeting with investors in Dubai this week, the people familiar with the matter were quoted as saying.

Bloomberg reported a spokesperson for Airtel Africa said the company remains committed to listing its mobile money business in the first half of 2026.

Citigroup ( C ) and Airtel Africa didn't immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie Closes Bretisilocin Acquisition
AbbVie Closes Bretisilocin Acquisition
Oct 17, 2025
09:28 AM EDT, 10/17/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it has closed the acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate bretisilocin. Bretisilocin is a psychedelic compound in phase 2 clinical development for the treatment of patients with moderate to severe major depressive disorder, AbbVie ( ABBV ) said. ...
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Neurocrine Biosciences Says Late-Stage Movement Disorder Study Shows Ingrezza's Therapeutic Efficacy at Lowest Available Dose
Oct 17, 2025
09:29 AM EDT, 10/17/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Friday that a new post-hoc analysis of a late-stage study showed clinically meaningful improvements in tardive dyskinesia symptoms in patients treated with Ingrezza at the lowest available dose of 40 mg. The company said 90% of participants who received continuous treatment for 48 weeks improved by at...
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Visionary Completes Controlling Stake in Sikang Health Industry Joint Venture Platform, Deepening Global Layout of TCM Health Preservation
Oct 17, 2025
TORONTO, Oct. 17, 2025 /PRNewswire/ -- Visionary Holdings Inc. ( GV ) , a Nasdaq-listed enterprise, announced today that it has completed the equity adjustment of Sikang (Guangzhou) Health Industry Investment Co., Ltd. (hereinafter referred to as the Joint Venture Company), a joint venture established with Guangzhou Sikang Investment Holding Co., Ltd. (hereinafter referred to as Guangzhou Sikang), and officially...
OBOOK Shares Fall Pre-Bell After Nasdaq Listing
OBOOK Shares Fall Pre-Bell After Nasdaq Listing
Oct 17, 2025
09:27 AM EDT, 10/17/2025 (MT Newswires) -- OBOOK ( OWLS ) shares were down 38% in Friday premarket activity, continuing their losses after the company's Nasdaq listing on Thursday. The company's shares closed at $55.55 on Thursday, down 18% from their $68 per share opening price. The company said that at the closing price on Thursday its market capitalization was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved